Literature DB >> 19100686

Pain in Parkinson's disease: Prevalence and characteristics.

A G Beiske1, J H Loge, A Rønningen, E Svensson.   

Abstract

Parkinson's disease is a chronic, progressive, incurable neurodegenerative disease. As the disease progresses, motor disturbances and non-motor symptoms represent considerable illness burdens. Symptom relief is the goal for the treatment. Pain is frequently observed in patients with Parkinson's disease, but its prevalence, characteristics and associations with Parkinson's disease are poorly documented. These were investigated in 176 home-living PD patients. They underwent a neurological examination and a structured interview for registration of pain characteristics in addition to responding to standardised questionnaires. Pain was reported by 146 (83%) patients. Compared to the general population, the Parkinson's disease patients experienced significantly more pain as measured by SF-36 Bodily Pain Scale. The average pain during the last 24h measured by the Brief Pain Inventory was 2.85. Fifty-three percent of the patients reported one, 24% reported two and 5% reported three pain types. Musculoskeletal pain was reported by 70%, dystonic pain by 40%, radicular-neuropathic pain by 20% and central neuropathic pain by 10%. Thirty-four percent were on analgesic medication. Pain was not associated with age, disease duration or severity of the disease; female gender was the only significant predictor of pain. Pain is frequent and disabling, independent of demographic and clinical variables except for female gender, and is significantly more common in Parkinson's patients compared to the general population. A minority of the Parkinson's disease patients with pain received analgesic medication. The findings call for improved attention to assessment and treatment of pain in the follow-up of Parkinson's disease patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100686     DOI: 10.1016/j.pain.2008.12.004

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  129 in total

1.  Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue.

Authors:  Hong-Bo Wen; Zhen-Xin Zhang; Han Wang; Ling Li; Honglei Chen; Yiming Liu; Baorong Zhang; Qun Xu
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Alterations of gene expression of sodium channels in dorsal root ganglion neurons of estrogen receptor knockout (ERKO) mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Haixia Ding; Qiang Wang; Jingli Liu; Wenyi Qian; Wenjuan Wang; Jun Wang; Rong Gao; Hang Xiao
Journal:  Endocrine       Date:  2012-02-28       Impact factor: 3.633

3.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 5.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

6.  Pain in patients attending outpatient rehabilitation: results of a pilot study.

Authors:  Francesca Cecchi; Anita Paperini; Raffaello Molino Lova; Guido Pasquini; Roberta Boni; Chiara Castagnoli; Federica Vannetti; Luca Padua; Claudio Macchi
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

7.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 9.  Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Authors:  José Alexandre S Crippa; Jaime E C Hallak; Antônio W Zuardi; Francisco S Guimarães; Vitor Tumas; Rafael G Dos Santos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-31       Impact factor: 5.270

10.  Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Authors:  Estelle Dellapina; Jean Pellaprat; Djilali Adel; Jerome Llido; Estelle Harroch; Jean Baptiste Martini; Aurélie Kas; Anne Sophie Salabert; Fabienne Ory-Magne; Pierre Payoux; Christine Brefel-Courbon
Journal:  J Neural Transm (Vienna)       Date:  2019-01-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.